skip to Main Content

High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer

Newsfeed image, light gray text on dark gray background
Pancreatic enzyme replacement therapy (PERT) is often an essential component of the treatment regimen for patients with pancreatic cancer, but it can be very pricey.

“Out-of-pocket costs for a 30-day supply of enzymes for Medicare beneficiaries can be as high as $1000,” commented Arjun Gupta, MD, an oncology fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Read more . . . 

Back To Top